Maxwellia is a pioneering ‘prescription to over the counter’ medicines company.
Maxwellia has raised €3.7M across 1 funding round from 1 investor, most recently a round in Apr 2021. Based in Alderley, UK; founded 2013; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-04-07 | Other | €3.7M |
| Praetura Ventures |
| View deal → |
